Transfer Mechanism of Ionic Drugs: Piroxicam as an agent facilitating proton transfer

Microliquid/Liquid Interfacial Sensors: Biomimetic Investigation of Transmembrane Mechanisms and Real-Time Determinations of Clemastine, Cyproheptadine, Epinastine, Cetirizine, and Desloratadine

Antihistamines relieve allergic symptoms by inhibiting the action of histamine. Further understanding of antihistamine transmembrane mechanisms and optimizing the selectivity and real-time monitoring capabilities of drug sensors is necessary. In this study, a micrometer liquid/liquid (L/L) interfacial sensor has served as a biomimetic membrane to investigate the mechanism of interfacial transfer of five antihistamines, i.e., clemastine (CLE), cyproheptadine (CYP), epinastine (EPI), desloratadine (DSL), and cetirizine (CET), and realize the real-time determinations. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques have been used to uncover the electrochemical transfer behavior of the five antihistamines at the L/L interface. Additionally, finite element simulations (FEMs) have been employed to reveal the thermodynamics and kinetics of the process. Visualization of antihistamine partitioning in two phases at different pH values can be realized by ion partition diagrams (IPDs). The IPDs also reveal the transfer mechanism at the L/L interface and provide effective lipophilicity at different pH values. Real-time determinations of these antihistamines have been achieved through potentiostatic chronoamperometry (I-t), exhibiting good selectivity with the addition of nine common organic or inorganic compounds in living organisms and revealing the potential for in vivo pharmacokinetics. Besides providing a satisfactory surrogate for studying the transmembrane mechanism of antihistamines, this work also sheds light on micro- and nano L/L interfacial sensors for in vivo analysis of pharmacokinetics at a single-cell or single-organelle level.

Distribution and Adsorption of Ionic Species into a Liposome Membrane and Their Dependence upon the Species and Concentration of a Coexisting Counterion

The distribution of ions into a bilayer lipid membrane (BLM) and their adsorption on the BLM are investigated by extracting a hydrophobic cation, rhodamine 6G (R6G⁺), into a liposome through the dialysis membrane method. R6G⁺ distribution mainly depends upon the concentration of the coexisting anion and its species (Cl^-, Br^-, BF₄^-, ClO₄^-, and picrate). On the other hand, R6G⁺ adsorption on the BLM surface follows the Langmuir adsorption model and is independent of the coexisting anion in the aqueous phase. We propose an extraction model of ionic species into the BLM, to explain the dependence of extraction of ionic species upon the coexisting anion. In this model, an ion is distributed with a coexisting counterion into the BLM and then forms an ion pair in the BLM. Here, the ion adsorption equilibrium on the BLM surface is independent of the species and concentration of the coexisting counterion under the same ionic strength. On the basis of this model, we estimate the distribution constant of R6G⁺ and anion (K_D), the ion-pair formation constant in the BLM (K_ip), and the R6G⁺ adsorption constant on the BLM surface (K_ad). Even for an ultrathin membrane system, such as a BLM, R6G⁺ is distributed with a coexisting counterion and the distribution equilibrium of the ionic species at the water-BLM interface is analyzable similar to that at the water-organic solvent interface.

Quantitative analysis of the structure–hydrophobicity relationship for di- and tripeptides based on voltammetric measurements with an oil/water interface

The transfer of 18 di- and 27 tripeptides with un-ionizable amino acid side chains at a nitrobenzene/water (NB/W) interface was studied by cyclic voltammetry. The reversible half-wave potential (E(r)(1/2)), i.e., the midpoint potential could be accurately determined at pH 2 for both the facilitated and non-facilitated transfers, respectively, in the presence and absence of dibenzo-18-crown-6 (DB18C6) in NB. A multiple linear regression analysis was then performed for the E(r)(1/2) using the 'corrected' Dubois steric parameter for amino acid side chain substitutents. The result shows that the hydrophobicity of the peptides is governed not only by the intrinsic hydrophobicity of the peptide backbone and side chains, but also by the steric effects of side chain substituents. For the non-facilitated transfer of peptides, the steric effect of a bulky side chain is more significant at the N-terminus than at the C-terminus (and central for tripeptides). The more bulky the side chain at the N-terminus, the less hydrophobic the peptide becomes due to inhibition of the solvation of a terminal -NH(3)(+) group by organic solvents. For the facilitated transfer by DB18C6, however, the steric effect of a bulky side chain is the most significant at the central position of a tripeptide. A MOPAC calculation of optimized structures of DB18C6-peptide complexes has also shown that there is a notable steric hindrance between the central side chain and the benzene rings of DB18C6, which would reduce the 'apparent' hydrophobicity or transferability of the tripeptide.

Drug permeation in biomembranes

In the past decades, it has become increasingly apparent that in addition to therapeutic effect, drugs need to exhibit favourable absorption, distribution, metabolism and excretion (ADME) characteristics to produce a desirable response in vivo. As the recent progress in drug discovery technology enables rapid synthesis of vast numbers of potential drug candidates, robust methods are required for the effective screening of compounds synthesized within such programs, so that compounds with poor pharmacokinetic properties can be rejected at an early stage of drug development. Furthermore, a viable in silico method would save resources by enabling virtual screening of drug candidates already prior to synthesis. This review gives a general overview of the approaches aimed at predicting biological permeation, one of the cornerstones behind the ADME behaviour of drugs. The most important experimental and computational models are reviewed. Physicochemical factors underlying the permeation process are discussed.

Fluorescence quenching of Acridine Orange in microemulsions induced by the non-steroidal anti-inflammatory drug Piroxicam

The singlet excited-state quenching of Acridine Orange (AO) by methyl viologen (MV2+) and the non-steroidal anti-inflammatory drug Piroxicam (Prx), incorporated in sodium bis(2-ethylhexyl) sulfosuccinate (AOT)/isooctane/water and Triton X-100 (Trx-100)/cyclohexane-hexanol/water (w/o) microemulsions, was followed by steady- and transient-state fluorescence. The water content was varied by using different values of omega 0 (omega 0 = [H2O]/[S]) at fixed AOT (0.1 M) and Trx-100 (0.2 M) concentrations. In AOT, MV2+ resides at the interface, while Prx partitions between the interface and bulk water, but considerably biased towards the latter compared to AO. The quenching process efficiency increases with increasing omega 0, but reaches a diffusional value similar to that of free water only for the case of Prx, underlining the electrostatic effect of the AOT interface. The quenching process in Trx-100 microemulsions is more efficient for Prx than for MV2+, pointing to a similar polyoxyethylene intra-chain location for the former and AO. In both cases, data obtained allowed the microviscosity of the aqueous interior at different omega 0 to be extrapolated and indicate an increase in eta w values with water content, reflecting changes in the shape of Trx-100 microemulsions, which occur at omega 0 = 8.

Evaluation and prediction of drug permeation

A major challenge confronting the pharmaceutical scientist is to optimize the selective and efficient delivery of new active entities and drug candidates. Successful drug development requires not only optimization of specific and potent pharmacodynamic activity, but also efficient delivery to the target site. Following advances in rational drug design, combinatorial chemistry and high-throughput screening techniques, the number of newly discovered and promising active compounds has increased dramatically in recent years, often making delivery problems the rate-limiting step in drug research. To overcome these problems, a good knowledge of the pharmacokinetic barriers encountered by bioactive compounds is required. This review gives an overview of the properties of relevant physiological barriers and presents some important biological models for evaluation of drug permeation and transport. Physicochemical determinants in drug permeation and the relevance of quantitative and qualitative approaches to the prediction and evaluation of passive drug absorption are also discussed.